News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

|Videos|March 24, 2023

Insights into Acne Management and Treatment Selection

Author(s)Linda Stein Gold, MD, Neal Bhatia, MD

Linda Stein-Gold, MD and Neal Bhatia, MD discuss their approach to acne management highlighting the novel utility of clascoterone cream 1% and where this fits into their treatment regimens.

Episodes in this series

EP. 1 Expert Perspective on the Clinical Management of Acne Vulgaris

EP. 1 Expert Perspective on the Clinical Management of Acne Vulgaris

EP. 2 Adapting Acne Management to Changing Patient Characteristics

EP. 2 Adapting Acne Management to Changing Patient Characteristics

EP. 3 Overview of Pediatric and Adult Acne Management

EP. 3 Overview of Pediatric and Adult Acne Management

EP. 4 Treatment Dosing Considerations in Pediatric Patients

EP. 4 Treatment Dosing Considerations in Pediatric Patients

EP. 5 Optimal Use Cases for Clascoterone Cream 1%

EP. 5 Optimal Use Cases for Clascoterone Cream 1%

EP. 6 Insights into Acne Management and Treatment Selection

EP. 6 Insights into Acne Management and Treatment Selection

EP. 7 Understanding Dosing Requirements with Isotretinoin

EP. 7 Understanding Dosing Requirements with Isotretinoin

EP. 8 Frontline Forum Part 1: Exploring Expert Perspectives on the Management of Acne Vulgaris

EP. 8 Frontline Forum Part 1: Exploring Expert Perspectives on the Management of Acne Vulgaris

EP. 9 Frontline Forum Part 2: Exploring Expert Perspectives on the Management of Acne Vulgaris

EP. 9 Frontline Forum Part 2: Exploring Expert Perspectives on the Management of Acne Vulgaris

EP. 10 Frontline Forum Part 3: Exploring Expert Perspectives on the Management of Acne Vulgaris

EP. 10 Frontline Forum Part 3: Exploring Expert Perspectives on the Management of Acne Vulgaris

EP. 11 Frontline Forum Part 4: Exploring Expert Perspectives on the Management of Acne Vulgaris

EP. 11 Frontline Forum Part 4: Exploring Expert Perspectives on the Management of Acne Vulgaris

EP. 12 Discovering Dermatology Times: June 2023 Acne Supplement

EP. 12 Discovering Dermatology Times: June 2023 Acne Supplement

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

Syrian Study Confirms Isotretinoin’s Effectiveness in Acne Treatment

ByMaddi Hebebrand, MC, Associate Editor

December 2nd 2025

Q&A: Dermatologists' Critical Role in Managing Cutaneous Toxicities in Lung Cancer Therapy

ByMarie Bosslett, Assistant Editor,Mondana Ghias, MD, FAAD

December 2nd 2025

Clinical Guidance Needed as Patients Turn to Tallow for Skin Conditions

ByMaddi Hebebrand, MC, Associate Editor

December 1st 2025

Elevate-Derm Takeaways: Acne Innovation, Alopecia Care, and Cross-Specialty Insights

ByJames Canner, PA-C,Kaitlyn Bader, Assistant Managing Editor

November 25th 2025

Journal Digest: November 19, 2025

ByMarie Bosslett, Assistant Editor

November 19th 2025

Latest CME

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

Brad P. Glick, DO, MPH, FAAD

Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes

Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes

Corey Cutler, MD, MPH, FRCP(C); Amin M. Alousi, MD; Mehdi Hamadani, MD; Anna Sureda, MD, PhD

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Hilary Baldwin; Neal Bhatia, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Revolutionizing Atopic Dermatitis (RAD) Conference 2026

In-Person Event

Revolutionizing Atopic Dermatitis (RAD) Conference 2026

June 17-19, 2026

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Brittany Weber MD, PhD, FACC, FAHA; Lourdes M. Perez-Chada MD, MMSc

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Diego Ruiz Dasilva, MD, FAAD; Brad Glick, DO, MPH. FAAD; Peter Lio, MD

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Jerry Bagel, MD, MS

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Trending on Dermatology Times

Transformative Advances This Year and Beyond

FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol

Phase 3b Study Confirms Ligelizumab’s Consistent CSU Control

The SkinCARE Questionnaire: Assessing the Psychological Dimensions of Skin Health Beyond Disease

Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population

© 2025 MJH Life Sciences^®

All rights reserved.